Gabelli Funds’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-100
Closed -$360K 1151
2018
Q3
$360K Hold
100
﹤0.01% 1051
2018
Q2
$360K Hold
100
﹤0.01% 1044
2018
Q1
$375K Buy
+100
New +$13.5K ﹤0.01% 1038

Other funds holding JNJ

Gabelli Funds's JNJ Position: Q1 2026 in Review

Gabelli Funds reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q1 2026, selling an estimated $1.16M and leaving 127,317 shares worth $31.1M. The position accounts for 0.21% of the portfolio, ranked #132.

Gabelli Funds first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.5M in Q2 2014. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gabelli Funds held 127,317 shares of Johnson & Johnson worth $31.1M as of Q1 2026.
  • Gabelli Funds sold 4,997 Johnson & Johnson shares in Q1 2026, an estimated $1.16M.
  • Johnson & Johnson made up 0.21% of Gabelli Funds's portfolio in Q1 2026, its #132 holding.
  • Gabelli Funds first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Gabelli Funds's Johnson & Johnson position peaked at $75.5M in Q2 2014.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.